Cargando…

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

In discharged survivors with COVID-19, impairment of diffusion capacity is the most common abnormality of lung function, followed by restrictive ventilatory defects, which are both associated with the severity of the disease https://bit.ly/2yUaBaT

Detalles Bibliográficos
Autores principales:	Mo, Xiaoneng, Jian, Wenhua, Su, Zhuquan, Chen, Mu, Peng, Hui, Peng, Ping, Lei, Chunliang, Chen, Ruchong, Zhong, Nanshan, Li, Shiyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236826/ https://www.ncbi.nlm.nih.gov/pubmed/32381497 http://dx.doi.org/10.1183/13993003.01217-2020

Ejemplares similares

Impaired pulmonary function in discharged patients with COVID-19: more work ahead
por: Chen, Ruchong, et al.
Publicado: (2020)

Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients
por: Gao, Yi, et al.
Publicado: (2021)

Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge
por: Nusair, Samir
Publicado: (2020)

Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months
por: Chen, Mu, et al.
Publicado: (2022)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Short-term outcomes of COVID-19 and risk factors for progression
por: Long, Li, et al.
Publicado: (2020)

Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients
por: Chapman, David G., et al.
Publicado: (2021)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
por: Jevnikar, Mitja, et al.
Publicado: (2021)

The high mental health burden of “Long COVID” and its association with on-going physical and respiratory symptoms in all adults discharged from hospital
por: Naidu, Sindhu B., et al.
Publicado: (2021)

Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China
por: Lu, Peng, et al.
Publicado: (2017)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
por: Guan, Lili, et al.
Publicado: (2020)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2019)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2020)

Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing
por: Kato, Kosuke, et al.
Publicado: (2021)

The use of online visual analogue scales in idiopathic pulmonary fibrosis
por: Moor, Catharina C., et al.
Publicado: (2022)

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
por: Stewart, Iain D., et al.
Publicado: (2021)

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis
por: Jacob, Joseph, et al.
Publicado: (2019)

Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic
por: Janapatla, Rajendra Prasad, et al.
Publicado: (2021)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Du, Rong-Hui, et al.
Publicado: (2020)

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
por: Sun, Thomas Yang, et al.
Publicado: (2022)

Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020)

In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography
por: Si-Mohamed, Salim, et al.
Publicado: (2020)

Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
por: Eapen, Mathew Suji, et al.
Publicado: (2020)

Pulmonary embolism in COVID-19: D-dimer threshold selection should not be based on maximising Youden's index
por: Korevaar, Daniël A., et al.
Publicado: (2021)

Cardiovascular comorbidity and its impact on patients with COVID-19
por: Guan, Wei-jie, et al.
Publicado: (2020)

FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
por: Nathan, Steven D., et al.
Publicado: (2020)

A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019
por: Ji, Mengyao, et al.
Publicado: (2020)

Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Cancer in the time of COVID-19: expert opinion on how to adapt current practice
por: Raskin, Jo, et al.
Publicado: (2020)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Response
por: Chen, Ruchong, et al.
Publicado: (2020)

Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT
por: van der Have, Oscar, et al.
Publicado: (2022)

Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis
por: Heinzelmann, Katharina, et al.
Publicado: (2022)

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
por: Klok, Frederikus A., et al.
Publicado: (2020)

Risk factors for viral RNA shedding in COVID-19 patients
por: Fu, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tt9i131mbk89m0bdushcl1789c